| Literature DB >> 35451179 |
David Guillén1, Alexandros Guekos2,3, Nadia Graf1, Barry Kim Humphreys1,3, Cynthia Peterson1,3, Petra Schweinhardt1,3.
Abstract
BACKGROUND: Pain chronicity is considered an important prognostic factor for outcome. Here, it was investigated whether pain duration influences outcome when only chronic patients (pain >3 months) are considered. Secondary aims were to determine, in patients of any pain duration, how much variance in outcome is explained by pain duration and whether pain duration truly predicts outcomes, that is out-of-sample prediction in independent data.Entities:
Mesh:
Year: 2022 PMID: 35451179 PMCID: PMC9324235 DOI: 10.1002/ejp.1954
Source DB: PubMed Journal: Eur J Pain ISSN: 1090-3801 Impact factor: 3.651
Demographic and clinical baseline variables
| Chronic patients ( | All patients ( | |
|---|---|---|
| Age in yrs, mean (SD) | 41.2 (13.9) | 41 (13.5) |
| Duration of symptoms in weeks, mean (SD) | 182 (285) | 62 (184) |
| Duration expectation, mean (SD) | 5.1 (2.7) | 4.1 (2.7) |
| NRS, mean (SD) | 5.51 (2.36) | 5.78 (2.25) |
| Bournemouth Questionnaire, total score (SD) | 30.3 (14.3) | 31.9 (15.2) |
| Gender | ||
| Female, | 162 (68%) | 470 (65%) |
| Male, | 76 (32%) | 250 (35%) |
| Marital status | ||
| Single | 91 (38%) | 270 (38%) |
| Married | 118 (50%) | 372 (52%) |
| Divorced or separated | 18 (8%) | 51 (7%) |
| Widow | 4 (2%) | 9 (1%) |
| Work status | ||
| Working (incl. Part time), | 189 (79%) | 582 (81%) |
| Not working (student, housewife, unemployed), | 32 (13%) | 78 (11%) |
| Disability pension, | 0 (0%) | 4 (1%) |
| Retired, | 16 (7%) | 42 (6%) |
| Smoker (yes), | 59 (25%) | 149 (21%) |
| General health | ||
| Good, | 122 (52%) | 442 (61%) |
| Average, | 103 (44%) | 231 (32%) |
| Poor, | 10 (4%) | 33 (5%) |
| Previous episodes | ||
| 0 prev. Episode, | 128 (54%) | 343 (48%) |
| 1 prev. Episode, | 10 (4%) | 102 (14%) |
| 2 prev. Episodes, | 5 (2%) | 32 (4%) |
| 3 prev. Episodes, | 4 (2%) | 21 (3%) |
| ≥4 prev. Episodes, | 1 (<1%) | 17 (2%) |
| Current pain medication (yes) | 67 (28%) | 235 (33%) |
| Radiculopathy (yes), | 28 (12%) | 103 (14%) |
Duration expectation: larger numbers indicate that patients expect their pain to last longer; Bournemouth Questionnaire: larger numbers indicate higher burden; NRS: numeric pain rating scale 0–10; SD: standard deviation. For some demographic and baseline variables, the numbers do not add up to the total number of patients because some did not respond to all questions. Chronic patients: patients with a pain duration >3 months.
The influence of pain duration on patient global impression of change (PGIC) and percent NRS change for chronic neck pain patients (pain duration >3 months) using different explanatory models
| FU time point | PGIC | Percent NRS change | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Linear | Quadratic | Cubic | Linear | Quadratic | Cubic | |||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |
| 1 week | 0.1 | 0.28 | 0.504 | 0.01 | 0.085 | 0.05 | 0.988 | <0.01 | 0.791 | <0.01 | 0.539 | <0.01 |
| 1 month | 0.297 | 0.21 | 0.749 | <0.01 | 0.228 | 0.03 | 0.997 | <0.01 | 0.978 | <0.01 | 0.791 | <0.01 |
| 3 months | 0.528 | 0.21 | 0.936 | <0.01 | 0.762 | <0.01 | 0.27 | 0.03 | 0.577 | <0.01 | 0.778 | <0.01 |
| 6 months | 0.35 | 0.23 | 0.959 | <0.01 | 0.836 | <0.01 | 0.622 | <0.01 | 0.994 | <0.01 | 0.785 | <0.01 |
| 12 months | 0.078 | 0.3 | 0.156 | 0.03 | 0.175 | 0.04 | 0.815 | <0.01 | 0.487 | <0.01 | 0.656 | <0.01 |
Note: Linear, quadratic and cubic fits were performed to determine whether the outcome variables (dichotomized PGIC or percent NRS change) at the different follow‐up time points depended on pain duration (in weeks) for chronic pain patients. The amount of variance explained by the respective independent variable is calculated as Nagelkerke's pseudo R 2 (dichotomized PGIC) or R 2 (percent NRS change). There was no significant influence of pain duration on outcome for any of the follow‐up time points.
A p‐value between 0.05 and 0.1 is considered a statistical trend. FU, follow‐up, p, p‐value.
Comparison of patient global impression of change (PGIC) and percent NRS change for chronic patients with pain duration of 3–6 months (n = 61) and over four years (n = 65)
| FU time point | PGIC | Percent NRS change |
|---|---|---|
|
|
| |
| 1 week |
|
|
| 1 month | 0.396 | 0.184 |
| 3 months | 0.549 | 0.81 |
| 6 months | 0.832 | 0.607 |
| 12 months | 0.44 | 0.346 |
Note: Statistical tests were performed with Pearson's χ 2 test of independence for categorical and Welch's t‐test for continuous data. Bold type face indicates a significant p‐value.
The influence of pain duration on patient global impression of change (PGIC) and percent NRS change in patients of any pain duration
| FU time point | PGIC | Percent NRS change | ||
|---|---|---|---|---|
|
|
|
|
| |
|
|
| 0.33 |
| 0.05 |
|
|
| 0.19 | 0.512 | <0.01 |
|
|
| 0.17 |
| 0.03 |
|
|
| 0.18 |
| 0.11 |
|
| 0.0517 | 0.16 |
| 0.05 |
Note: Regression analyses were performed to determine whether the outcome variables (dichotomized PGIC or percent NRS change) at the different follow‐up time points depended on pain duration (in weeks). The amount of variance explained by the respective independent variable is calculated as Nagelkerke's pseudo R 2 (dichotomized PGIC) or R 2 (percent NRS change). A significant influence of pain duration on outcome is indicated by bold type face.
p‐value between 0.05 and 0.1 is considered a statistical trend. FU: follow‐up. At each FU time point the number of data points (PGIC, Percent NRS change) are given.
Patient improvement
| FU time point | PGIC ‘improved’ | Any NRS reduction | NRS reduction of 30% or more | |||
|---|---|---|---|---|---|---|
| All patients ( | Chronic patients ( | All patients ( | Chronic patients ( | All patients ( | Chronic patients ( | |
| 1 week | 58% | 38% | 76% | 65% | 48% | 56% |
| 1 month | 74% | 62% | 85% | 79% | 76% | 66% |
| 3 months | 78% | 69% | 87% | 80% | 78% | 69% |
| 6 months | 78% | 67% | 89% | 79% | 78% | 64% |
| 1 year | 82% | 74% | 89% | 84% | 83% | 74% |
Note: Percentages of patients who reported improvement according to PGIC or percent NRS change and of patients who reported a reduction of NRS > = 30%. FU: follow‐up Chronic patients: patients with a pain duration >3 months.